Published in J Virol on August 01, 1997
Cloning and characterization of adeno-associated virus type 5. J Virol (1999) 3.36
Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes. J Virol (1999) 1.55
Inhibition of PrKX, a novel protein kinase, and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2. Mol Cell Biol (1998) 1.20
How adeno-associated virus Rep78 protein arrests cells completely in S phase. Proc Natl Acad Sci U S A (2005) 1.15
Identification of cellular proteins that interact with the adeno-associated virus rep protein. J Virol (2008) 1.12
Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. EMBO J (2000) 1.10
Adeno-associated virus Rep78 protein interacts with protein kinase A and its homolog PRKX and inhibits CREB-dependent transcriptional activation. J Virol (1998) 1.09
Bocavirus infection induces mitochondrion-mediated apoptosis and cell cycle arrest at G2/M phase. J Virol (2010) 1.08
Human cytomegalovirus protein pUL117 targets the mini-chromosome maintenance complex and suppresses cellular DNA synthesis. PLoS Pathog (2010) 0.97
AAV recombineering with single strand oligonucleotides. PLoS One (2009) 0.94
Adeno-associated virus type 2 increases proteosome-dependent degradation of p21WAF1 in a human papillomavirus type 31b-positive cervical carcinoma line. J Virol (2006) 0.93
Functional interactions between herpesvirus oncoprotein MEQ and cell cycle regulator CDK2. J Virol (1999) 0.91
Overexpression of cyclin A inhibits augmentation of recombinant adeno-associated virus transduction by the adenovirus E4orf6 protein. J Virol (1999) 0.90
Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication. J Virol (2013) 0.87
Identification of an adeno-associated virus Rep protein binding site in the adenovirus E2a promoter. J Virol (2005) 0.86
SMC1-mediated intra-S-phase arrest facilitates bocavirus DNA replication. J Virol (2013) 0.86
Adeno-associated virus type 2 induces apoptosis in human papillomavirus-infected cell lines but not in normal keratinocytes. J Virol (2009) 0.82
Rapid transgene expression in multiple precursor cell types of adult rat subventricular zone mediated by adeno-associated type 1 vectors. Hum Gene Ther (2012) 0.81
Adeno-associated virus induces apoptosis during coinfection with adenovirus. Virology (2006) 0.80
Adeno-associated virus type 2 infection activates caspase dependent and independent apoptosis in multiple breast cancer lines but not in normal mammary epithelial cells. Mol Cancer (2011) 0.80
Cell cycle-dependent expression of AAV2 Rep in HSV-1 co-infections gives rise to a mosaic of cells replicating either AAV2 or HSV-1. J Virol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell (1993) 33.20
p21 is a universal inhibitor of cyclin kinases. Nature (1993) 15.55
Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev (1995) 13.66
p53: puzzle and paradigm. Genes Dev (1996) 13.16
Principles of CDK regulation. Nature (1995) 13.09
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell (1994) 9.25
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res (1994) 9.00
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (1994) 8.22
Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (1995) 7.25
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell (1994) 7.05
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res (1994) 6.16
p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (1995) 6.01
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev (1995) 5.63
Retinoblastoma protein switches the E2F site from positive to negative element. Nature (1992) 5.47
Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A (1995) 4.54
Phosphorylation and activation of human cdc25-C by cdc2--cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J (1993) 4.33
Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci U S A (1995) 3.95
Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science (1996) 3.70
Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol (1986) 3.67
Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res (1994) 3.54
Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev (1993) 3.41
Parvovirus replication. Microbiol Rev (1990) 3.37
MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol (1995) 3.32
Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev (1994) 3.27
CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev (1996) 3.27
Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev (1995) 3.02
Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene (1996) 2.96
Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes. Mol Cell Biol (1987) 2.85
Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70
p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev (1995) 2.60
Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A (1993) 2.55
Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol (1989) 2.53
Cdk inhibitors in development and cancer. Curr Opin Genet Dev (1996) 2.48
Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc Natl Acad Sci U S A (1995) 2.48
Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene (1994) 2.47
Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene (1994) 2.43
Association of cdk2 kinase with the transcription factor E2F during S phase. Science (1992) 2.37
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev (1995) 2.33
Cell cycle checkpoints. Curr Opin Cell Biol (1994) 2.26
Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol (1994) 2.12
Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol Cell Biol (1996) 1.97
The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus. Virology (1989) 1.95
Transcriptional regulation during the mammalian cell cycle. Trends Genet (1995) 1.73
Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. J Virol (1995) 1.71
The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci (1992) 1.68
Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology (1981) 1.65
Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein. J Virol (1995) 1.63
Inhibition of cellular transformation by the adeno-associated virus rep gene. Virology (1991) 1.55
p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity. Oncogene (1996) 1.53
Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product. Cancer Res (1991) 1.49
Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels. J Virol (1994) 1.48
Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J Virol (1994) 1.46
Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17. J Virol (1992) 1.45
A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol (1996) 1.43
Inhibition of adenovirus 12 oncogenicity by adeno-associated virus. Proc Soc Exp Biol Med (1968) 1.41
Mammalian G1 cyclins. Curr Opin Cell Biol (1994) 1.39
p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol Cell Biol (1997) 1.37
Perturbation of the cell cycle by adeno-associated virus. Virology (1988) 1.30
Inhibition of adenovirus oncogenicity in hamsters by adeno-associated virus DNA. J Natl Cancer Inst (1981) 1.30
Influence of adeno-associated satellite virus on adenovirus-induced tumours in hamsters. Nat New Biol (1973) 1.28
p21 Disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol (1996) 1.16
E2F and the molecular mechanisms of early cell-cycle control. Biochem Soc Trans (1996) 1.14
Effect of adeno-associated virus on cancer expression by herpesvirus-transformed hamster cells. J Natl Cancer Inst (1975) 1.12
The Rep68 protein of adeno-associated virus type 2 stimulates expression of the platelet-derived growth factor B c-sis proto-oncogene. J Virol (1996) 1.11
Effect of a viral rep gene on transformation of cells by an adeno-associated virus vector. Virology (1988) 1.10
Adeno-associated viruses inhibit SV40 DNA amplification and replication of herpes simplex virus in SV40-transformed hamster cells. Virology (1988) 1.09
Selective killing of carcinogen-treated SV40-transformed Chinese hamster cells by a defective parvovirus. Virology (1984) 1.03
Influence of adeno-associated virus on adherence and growth properties of normal cells. J Virol (1992) 1.02
Adeno-associated parvoviruses inhibit growth of cells derived from malignant human tumors. Int J Cancer (1990) 1.01
The tumor suppressive properties of adeno-associated viruses. Mutat Res (1994) 1.01
Tumor suppression. Lessons in p16 from phylum Falconium. Curr Biol (1995) 0.96
Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Oncogene (1994) 0.94
Induction of differentiation-associated changes in established human cells by infection with adeno-associated virus type 2. J Virol (1992) 0.91
Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells. Oncogene (1996) 0.90
Adeno-associated virus sensitizes HeLa cell tumors to gamma rays. J Virol (1992) 0.89
The retinoblastoma tumor suppressor protein. Curr Opin Genet Dev (1995) 0.86
Growth properties of a human melanoma cell line are altered by adeno-associated parvovirus type 2. Int J Cancer (1995) 0.86
Infection with adeno-associated parvovirus leads to increased sensitivity of mammalian cells to stress. Virology (1991) 0.85
Improved efficacy of chemotherapy by parvovirus-mediated sensitisation of human tumour cells. Eur J Cancer (1996) 0.75
Genetic and physical maps of Saccharomyces cerevisiae. Nature (1997) 21.48
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
A new generation of the IMAGIC image processing system. J Struct Biol (1996) 12.57
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (1985) 11.11
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28
Concentration of Indole-3-acetic Acid and Its Derivatives in Plants. Plant Physiol (1977) 10.03
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature (1978) 9.25
RPS2 of Arabidopsis thaliana: a leucine-rich repeat class of plant disease resistance genes. Science (1994) 8.99
EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (1970) 8.08
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med (2000) 7.48
Concentrations of Indole-3-acetic Acid and Its Esters in Avena and Zea. Plant Physiol (1974) 7.28
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
Synthesis of 4,5,6,7 and 2,4,5,6,7 Deuterium-labeled Indole-3-Acetic Acid for Use in Mass Spectrometric Assays. Plant Physiol (1980) 6.14
Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology (1993) 5.72
Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol (1982) 5.49
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol (1977) 5.21
Single-particle electron cryo-microscopy: towards atomic resolution. Q Rev Biophys (2000) 4.86
FCA, a gene controlling flowering time in Arabidopsis, encodes a protein containing RNA-binding domains. Cell (1997) 4.79
The Arabidopsis downy mildew resistance gene RPP5 shares similarity to the toll and interleukin-1 receptors with N and L6. Plant Cell (1997) 4.53
Molecular cloning of viral DNA from human genital warts. J Virol (1981) 4.50
Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet (1982) 4.31
Analysis of human genital warts (condylomata acuminata) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer (1982) 4.30
The nucleotide sequence and genome organization of human papilloma virus type 11. Virology (1986) 4.04
Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int J Cancer (1980) 4.03
Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther (1998) 4.03
Double-standard isotope dilution assay. I. Quantitative assay of indole-3-acetic acid. Anal Biochem (1981) 3.90
Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol (1987) 3.70
Photo-regulation of the ratio of ester to free indole-3-acetic acid. Biochem Biophys Res Commun (1977) 3.69
Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol (1999) 3.67
Specific C-receptors for itch in human skin. J Neurosci (1997) 3.51
Distribution of Free and Ester Indole-3-Acetic Acid in the Cortex and Stele of the Zea mays Mesocotyl. Plant Physiol (1982) 3.28
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol (2003) 3.25
A novel zinc finger protein is encoded by the Arabidopsis LSD1 gene and functions as a negative regulator of plant cell death. Cell (1997) 2.91
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol (1973) 2.71
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood (2000) 2.70
Construction of an intron-containing marker gene: splicing of the intron in transgenic plants and its use in monitoring early events in Agrobacterium-mediated plant transformation. Mol Gen Genet (1990) 2.69
Condylomata acuminata and human genital cancer. Cancer Res (1976) 2.67
Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev (2000) 2.62
Validation of a radioimmunoassay for indole-3-acetic Acid using gas chromatography-selected ion monitoring-mass spectrometry. Plant Physiol (1981) 2.60
Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H. J Virol (1985) 2.56
Response to gravity by Zea mays seedlings. I. Time course of the response. Plant Physiol (1984) 2.55
Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci U S A (1979) 2.55
Forespore-specific transcription of a gene in the signal transduction pathway that governs Pro-sigma K processing in Bacillus subtilis. Genes Dev (1991) 2.53
Complete DNA sequence of lymphotropic papovavirus: prototype of a new species of the polyomavirus genus. Virology (1985) 2.53
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl (2000) 2.52
Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology (1984) 2.49
DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J (2001) 2.43
Partial purification of the Epstein-Barr virus and some properties of its DNA. Virology (1970) 2.39
Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol (2003) 2.39
DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res (1988) 2.39
Effect of Deseeding on the Indole-3-acetic Acid Content of Shoots and Roots of Zea mays Seedlings. Plant Physiol (1983) 2.36
Subcellular compartmentalization of adeno-associated virus type 2 assembly. J Virol (1997) 2.31
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol (2001) 2.30
Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer (1983) 2.30
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus. Virology (1986) 2.26
Molecular characterization of a karyophilic, histone-binding protein: cDNA cloning, amino acid sequence and expression of nuclear protein N1/N2 of Xenopus laevis. EMBO J (1986) 2.25
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology (2005) 2.24
Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother (1993) 2.23
Lymphotropic papovaviruses isolated from African green monkey and human cells. Med Microbiol Immunol (1979) 2.23
Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells. J Virol (1984) 2.23
Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm. J Biol Chem (1994) 2.23
A comparative linkage map of oilseed rape and its use for QTL analysis of seed oil and erucic acid content. Theor Appl Genet (2006) 2.21
Identification and map position of YAC clones comprising one-third of the Arabidopsis genome. Plant J (1991) 2.17
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope (1997) 2.15
Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology (1984) 2.13
Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet (1987) 2.13
Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology (2011) 2.11
ClpS is an essential component of the N-end rule pathway in Escherichia coli. Nature (2006) 2.09
Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol (1967) 2.07
Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology (1988) 2.03
Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol (2001) 2.02
Oncogenic Herpes viruses. Biochim Biophys Acta (1975) 2.01
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J Virol (1990) 2.00
Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-volta. Int J Cancer (1981) 1.99
Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer (1974) 1.98
Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol (1999) 1.94
NC37-R1 Epstein-Barr virus (EBV): a possible recombinant between intracellular NC37 viral DNA and superinfecting P3HR-1 EBV. Intervirology (1980) 1.92
Gravitational effects on plant growth hormone concentration. Adv Space Res (1983) 1.91
Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis. Am J Hum Genet (1998) 1.87
Efficient transformation of Arabidopsis thaliana using direct gene transfer to protoplasts. Mol Gen Genet (1989) 1.86
Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. J Virol (1995) 1.86
Identification of mutants in metabolically regulated gene expression. Plant J (1997) 1.86
Analysis of early and late Epstein-Barr virus associated polypeptides by immunoprecipitation. Virology (1979) 1.85
White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke (1988) 1.85
Multidrug resistance in Candida albicans: disruption of the BENr gene. Antimicrob Agents Chemother (1995) 1.84
CT and MRI rating of white matter lesions. Cerebrovasc Dis (2002) 1.83
Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet (1986) 1.82
Comparative sequence analysis reveals extensive microcolinearity in the lateral suppressor regions of the tomato, Arabidopsis, and Capsella genomes. Plant Cell (2001) 1.79
Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay. Kidney Int (2006) 1.79
Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med (1996) 1.79